Y

Yili Chuanning Biotechnology Co Ltd
SZSE:301301

Watchlist Manager
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Watchlist
Price: 12.8 CNY -5.26% Market Closed
Market Cap: 28.5B CNY
Have any thoughts about
Yili Chuanning Biotechnology Co Ltd?
Write Note

Relative Value

The Relative Value of one Yili Chuanning Biotechnology Co Ltd stock under the Base Case scenario is 17.83 CNY. Compared to the current market price of 12.8 CNY, Yili Chuanning Biotechnology Co Ltd is Undervalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
17.83 CNY
Undervaluation 28%
Relative Value
Price
Y
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
12
vs Industry
Median 3Y
4.3
Median 5Y
4.3
Industry
7.7
Forward
4.6
vs History
19
vs Industry
Median 3Y
19.9
Median 5Y
19.9
Industry
22.7
Forward
18.7
vs History
7
vs Industry
Median 3Y
10.9
Median 5Y
10.9
Industry
21.6
vs History
24
vs Industry
Median 3Y
-31.9
Median 5Y
-31.9
Industry
25.2
vs History
0
vs Industry
Median 3Y
3.3
Median 5Y
3.3
Industry
2.5
vs History
12
vs Industry
Median 3Y
4.5
Median 5Y
4.5
Industry
7.7
Forward
4.8
vs History
19
vs Industry
Median 3Y
13.9
Median 5Y
13.9
Industry
9
vs History
19
vs Industry
Median 3Y
16.7
Median 5Y
16.7
Industry
4.2
Forward
11.7
vs History
19
vs Industry
Median 3Y
16.7
Median 5Y
16.7
Industry
4.1
Forward
15.3
vs History
12
vs Industry
Median 3Y
11.1
Median 5Y
11.1
Industry
5.7
vs History
16
vs Industry
Median 3Y
12.5
Median 5Y
12.5
Industry
3.6
vs History
0
vs Industry
Median 3Y
2.6
Median 5Y
2.6
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Yili Chuanning Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
28.5B CNY 5.1 21.7 18 18
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
CN
Y
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Average P/E: 177
21.7
120%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Y
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Average EV/EBITDA: 17.3
18
164%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
Y
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Average EV/EBIT: 21.9
18
113%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top